Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Category Archives: Marketing
Unbranded Pharma Sites Gain Traction
Image by alles-schlumpf via Flickr
The popularity of unbranded pharma Web sites amongst consumers appears to be on an up tick, according to new data released by Manhattan Research this week.
The report, “Unbranded Web sites: Brand Reach throughout the Patient Life Cycle” looked at how many consumers actively use unbranded pharma sites and to what degree [...]
Posted in Marketing Tagged Conditions and Diseases, Data, Health, Manhattan Research, Monique Levy, Prescription drug, WebMD, World Wide Web Leave a comment
PhRMA Calls for New Style Search Link Ads
The Pharmaceutical Research and Manufacturers of America (PhRMA), on Tuesday, revealed its comments to FDA about how to handle search link ads on sites such as Google and Yahoo.
PhRMA showed off two versions of its recommended search ad, one with a universal symbol that’s easily recognizable as a link to risk information (the sample one [...]
Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant
Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later.
But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]
Also posted in Corporate Responsibility, FDA, News, Safety, Strategy Tagged Casodex, chronic pain, Dexilant, dexlansoprazole, dispensing error, FDA, Kadian, Kapidex, Prostate cancer, proton pump inhibitor, Takeda 2 Comments
Tweeting to Your Facebook: Why Pharma Is So Bad With Social Media
For those of you who didn’t know, it’s Social Media Week. Granted, the week is almost over, but the panel that you all care about didn’t take place until yesterday afternoon here in NYC.
The panel’s mouthful of a name—“Navigating Social Media & New Technology in Healthcare & Pharmaceutical Industries”—is nevertheless an accurate description of the [...]
Also posted in E-Media Tagged adverse events, DJ Edgerton, Facebook, Jay Parkinson, Lipitor, Marketing, Saatchi, social media, Twitter, Zemoga 2 Comments

Novartis Hits Regulatory Snag with Facebook Widget